Difference between revisions of "Fluorouracil (5-FU)"
Warner-admin (talk | contribs) m (Text replacement - "manufacturer. Instead" to "manufacturer. Instead") |
m |
||
Line 11: | Line 11: | ||
*[[Breast cancer]] | *[[Breast cancer]] | ||
*[[Cervical cancer]] | *[[Cervical cancer]] | ||
+ | *[[Cholangiocarcinoma]] | ||
*[[Colon cancer]] | *[[Colon cancer]] | ||
*[[Esophageal cancer]] | *[[Esophageal cancer]] | ||
*[[Gastric cancer]] | *[[Gastric cancer]] | ||
*[[Head and neck cancer]] | *[[Head and neck cancer]] | ||
− | *[[ | + | *[[Hepatocellular carcinoma]] |
+ | *[[Nasopharyngeal carcinoma]] | ||
*[[Neuroendocrine tumors]] | *[[Neuroendocrine tumors]] | ||
*[[Pancreatic cancer]] | *[[Pancreatic cancer]] | ||
Line 21: | Line 23: | ||
*[[Prostate cancer]] | *[[Prostate cancer]] | ||
*[[Rectal cancer]] | *[[Rectal cancer]] | ||
− | *[[ | + | *[[SCC of unknown primary]] |
+ | |||
+ | ==Diseases for which it was used== | ||
+ | *[[Diffuse large B-cell lymphoma - obsolete|Diffuse large B-cell lymphoma]] | ||
==Patient drug information== | ==Patient drug information== | ||
Line 31: | Line 36: | ||
==Also known as== | ==Also known as== | ||
+ | *'''Generic names:''' 5 Fluorouracil, 5 FU, 5-fluoracilo, 5-fluorouracilo, 5-fluorouracyl, FU | ||
+ | *'''Brand names:''' | ||
{| border="1" style="text-align:center;" | {| border="1" style="text-align:center;" | ||
!colspan="8" align="center" style="background-color:#0066FF"| '''Synonyms''' | !colspan="8" align="center" style="background-color:#0066FF"| '''Synonyms''' | ||
|- | |- | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|Accusite | |Accusite | ||
|Actino Hermal | |Actino Hermal | ||
Line 51: | Line 47: | ||
|Benton | |Benton | ||
|Biofur | |Biofur | ||
− | |||
|Carac | |Carac | ||
|Carebin | |Carebin | ||
+ | |- | ||
|Carzonal | |Carzonal | ||
|Cinco-FU | |Cinco-FU | ||
Line 60: | Line 56: | ||
|Effcil | |Effcil | ||
|Efudex | |Efudex | ||
− | |||
|Efurix | |Efurix | ||
|Ezadex | |Ezadex | ||
+ | |- | ||
|Fauldfluor | |Fauldfluor | ||
|Fivocil | |Fivocil | ||
Line 69: | Line 65: | ||
|Flonida | |Flonida | ||
|Florac | |Florac | ||
− | |||
− | |||
|Fluhomer | |Fluhomer | ||
|Fluolex | |Fluolex | ||
+ | |- | ||
+ | |Fluoroplex | ||
|Fluor-Uracil | |Fluor-Uracil | ||
|Fluoro-Uracile ICN | |Fluoro-Uracile ICN | ||
|Fluoro-Uracil ICN | |Fluoro-Uracil ICN | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|Fluorouracile | |Fluorouracile | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|Fluorouracilo | |Fluorouracilo | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|Fluorourcil | |Fluorourcil | ||
|Fluoruracilo | |Fluoruracilo | ||
+ | |- | ||
|Fluoxan | |Fluoxan | ||
|Flurablastin | |Flurablastin | ||
− | |||
|Flurac | |Flurac | ||
|Fluracedyl | |Fluracedyl | ||
Line 112: | Line 85: | ||
|Fluroblastine | |Fluroblastine | ||
|Ftoruracil | |Ftoruracil | ||
+ | |- | ||
|Ftouracil | |Ftouracil | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|Haemato-FU | |Haemato-FU | ||
|Ifacil | |Ifacil | ||
Line 123: | Line 92: | ||
|Kecimeton Tatumi | |Kecimeton Tatumi | ||
|Killit | |Killit | ||
+ | |Lunachol | ||
+ | |Lunapon | ||
|- | |- | ||
− | |||
− | |||
− | |||
− | |||
|Natira U | |Natira U | ||
|Neofluor | |Neofluor | ||
|O Fluor | |O Fluor | ||
|Oncofu | |Oncofu | ||
− | |||
|Onkofluor | |Onkofluor | ||
|Pentafu | |Pentafu | ||
|Pharmauracil | |Pharmauracil | ||
|Phthoruracil | |Phthoruracil | ||
+ | |- | ||
|Phtoruracil | |Phtoruracil | ||
|Ribofluor | |Ribofluor | ||
|Rotianin | |Rotianin | ||
− | |||
− | |||
|Satelol | |Satelol | ||
|Seco Uracil | |Seco Uracil | ||
|Tecflu | |Tecflu | ||
|Timadin | |Timadin | ||
− | |||
− | |||
|Triosules | |Triosules | ||
+ | |- | ||
|Uflahex | |Uflahex | ||
− | |||
|Ulosagen | |Ulosagen | ||
− | |Ulup | + | |Ulup |
− | |||
|Uraciflor | |Uraciflor | ||
|Utoral | |Utoral | ||
|Vaflu | |Vaflu | ||
|Vafu | |Vafu | ||
− | |||
|- | |- | ||
|} | |} | ||
Line 166: | Line 127: | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
− | |||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Topical medications]] | [[Category:Topical medications]] | ||
Line 176: | Line 136: | ||
[[Category:Bladder cancer medications]] | [[Category:Bladder cancer medications]] | ||
[[Category:Breast cancer medications]] | [[Category:Breast cancer medications]] | ||
− | |||
[[Category:Cervical cancer medications]] | [[Category:Cervical cancer medications]] | ||
+ | [[Category:Cholangiocarcinoma medications]] | ||
[[Category:Colon cancer medications]] | [[Category:Colon cancer medications]] | ||
[[Category:Esophageal cancer medications]] | [[Category:Esophageal cancer medications]] | ||
[[Category:Gastric cancer medications]] | [[Category:Gastric cancer medications]] | ||
[[Category:Head and neck cancer medications]] | [[Category:Head and neck cancer medications]] | ||
− | [[Category: | + | [[Category:Hepatocellular carcinoma medications]] |
− | [[Category: | + | [[Category:Nasopharyngeal carcinoma medications]] |
[[Category:Pancreatic cancer medications]] | [[Category:Pancreatic cancer medications]] | ||
+ | [[Category:Pancreatic NET medications]] | ||
[[Category:Penile cancer medications]] | [[Category:Penile cancer medications]] | ||
[[Category:Prostate cancer medications]] | [[Category:Prostate cancer medications]] | ||
[[Category:Rectal cancer medications]] | [[Category:Rectal cancer medications]] | ||
+ | [[Category:SCC of unknown primary medications]] | ||
[[Category:Drugs FDA approved in 1962]] | [[Category:Drugs FDA approved in 1962]] | ||
[[Category:WHO Essential Cancer Medicine]] | [[Category:WHO Essential Cancer Medicine]] |
Revision as of 18:51, 21 January 2018
General information
Class/mechanism: Pyrimidine analog, antimetabolite, inhibitor of thymidylate synthase. Metabolized to 5-fluoro-2'-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP). FdUMP inhibits DNA synthesis by binding to thymidylate synthase and inhibiting production of thymidylate; FUTP interferes with RNA processing when it is mistakenly incorporated in place of uridine triphosphate (UTP).[1][2].
Route: IV
Extravasation: irritant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Anal cancer
- Bladder cancer
- Breast cancer
- Cervical cancer
- Cholangiocarcinoma
- Colon cancer
- Esophageal cancer
- Gastric cancer
- Head and neck cancer
- Hepatocellular carcinoma
- Nasopharyngeal carcinoma
- Neuroendocrine tumors
- Pancreatic cancer
- Penile cancer
- Prostate cancer
- Rectal cancer
- SCC of unknown primary
Diseases for which it was used
Patient drug information
- Fluorouracil (5-FU) patient drug information (Chemocare)[3]
- Fluorouracil (5-FU) patient drug information (UpToDate)[4]
History of changes in FDA indication
- 4/25/1962: Initial FDA approval
Also known as
- Generic names: 5 Fluorouracil, 5 FU, 5-fluoracilo, 5-fluorouracilo, 5-fluorouracyl, FU
- Brand names:
Synonyms | |||||||
---|---|---|---|---|---|---|---|
Accusite | Actino Hermal | Adrucil | Arumel | Benton | Biofur | Carac | Carebin |
Carzonal | Cinco-FU | Cinkef-U | Curacil | Effcil | Efudex | Efurix | Ezadex |
Fauldfluor | Fivocil | Fivoflu | Flacule | Flonida | Florac | Fluhomer | Fluolex |
Fluoroplex | Fluor-Uracil | Fluoro-Uracile ICN | Fluoro-Uracil ICN | Fluorouracile | Fluorouracilo | Fluorourcil | Fluoruracilo |
Fluoxan | Flurablastin | Flurac | Fluracedyl | Fluracil | Fluroblastin | Fluroblastine | Ftoruracil |
Ftouracil | Haemato-FU | Ifacil | Kang Ning | Kecimeton Tatumi | Killit | Lunachol | Lunapon |
Natira U | Neofluor | O Fluor | Oncofu | Onkofluor | Pentafu | Pharmauracil | Phthoruracil |
Phtoruracil | Ribofluor | Rotianin | Satelol | Seco Uracil | Tecflu | Timadin | Triosules |
Uflahex | Ulosagen | Ulup | Uraciflor | Utoral | Vaflu | Vafu |
References
- Drug index
- Intravenous medications
- Topical medications
- Irritant chemotherapy
- Fluoropyrimidines
- Anal cancer medications
- Bladder cancer medications
- Breast cancer medications
- Cervical cancer medications
- Cholangiocarcinoma medications
- Colon cancer medications
- Esophageal cancer medications
- Gastric cancer medications
- Head and neck cancer medications
- Hepatocellular carcinoma medications
- Nasopharyngeal carcinoma medications
- Pancreatic cancer medications
- Pancreatic NET medications
- Penile cancer medications
- Prostate cancer medications
- Rectal cancer medications
- SCC of unknown primary medications
- Drugs FDA approved in 1962
- WHO Essential Cancer Medicine